Going into effect on Jan. 1, 2025, the approvals could increase patient access to the new hypertension treatments.

Medtronic secured a Transitional Pass-Through (TPT) payment under the Medicare Hospital Outpatient Prospective Payment System for its Symplicity Spyral renal denervation catheter. The TCT status, granted by the Centers for Medicare and Medicaid Services (CMS), applies to the Symplicity blood pressure procedure and aims to reduce cost barriers for healthcare providers.